60 Degrees Pharmaceuticals stock swings again: SXTP slides in premarket after Runway Health deal pop
60 Degrees Pharmaceuticals shares fell 9.9% to $4.54 in Friday premarket trading, after soaring 152% the previous session on news of a Runway Health partnership to launch telehealth sales of its malaria pill ARAKODA starting April 2. The company executed a 1-for-4 reverse stock split on Jan. 20 to meet Nasdaq listing requirements.
